236 related articles for article (PubMed ID: 31845972)
1. Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation.
Chen YL; Gomes T; Hardman CS; Vieira Braga FA; Gutowska-Owsiak D; Salimi M; Gray N; Duncan DA; Reynolds G; Johnson D; Salio M; Cerundolo V; Barlow JL; McKenzie ANJ; Teichmann SA; Haniffa M; Ogg G
J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31845972
[TBL] [Abstract][Full Text] [Related]
2. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
J Immunol Methods; 2010 Oct; 362(1-2):168-75. PubMed ID: 20888334
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls.
Van Vré EA; Bosmans JM; Van Brussel I; Maris M; De Meyer GR; Van Schil PE; Vrints CJ; Bult H
Pathology; 2011 Apr; 43(3):239-47. PubMed ID: 21436634
[TBL] [Abstract][Full Text] [Related]
4. BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy decidua.
Ban YL; Kong BH; Qu X; Yang QF; Ma YY
Clin Exp Immunol; 2008 Mar; 151(3):399-406. PubMed ID: 18234052
[TBL] [Abstract][Full Text] [Related]
5. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production.
Fanning SL; George TC; Feng D; Feldman SB; Megjugorac NJ; Izaguirre AG; Fitzgerald-Bocarsly P
J Immunol; 2006 Nov; 177(9):5829-39. PubMed ID: 17056507
[TBL] [Abstract][Full Text] [Related]
6. CD1c+ and CD303+ dendritic cells in peripheral blood, lymph nodes and tumor tissue of patients with non-small cell lung cancer.
Tabarkiewicz J; Rybojad P; Jablonka A; Rolinski J
Oncol Rep; 2008 Jan; 19(1):237-43. PubMed ID: 18097601
[TBL] [Abstract][Full Text] [Related]
7. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
8. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
9. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions.
Woltman AM; de Fijter JW; Zuidwijk K; Vlug AG; Bajema IM; van der Kooij SW; van Ham V; van Kooten C
Kidney Int; 2007 May; 71(10):1001-8. PubMed ID: 17361115
[TBL] [Abstract][Full Text] [Related]
10. Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid.
Tsoumakidou M; Tzanakis N; Papadaki HA; Koutala H; Siafakas NM
Immunol Cell Biol; 2006 Jun; 84(3):267-73. PubMed ID: 16509829
[TBL] [Abstract][Full Text] [Related]
11. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects.
Corrigan CJ; Jayaratnam A; Wang Y; Liu Y; de Waal Malefyt R; Meng Q; Kay AB; Phipps S; Lee TH; Ying S
Allergy; 2009 Jul; 64(7):1014-22. PubMed ID: 19187393
[TBL] [Abstract][Full Text] [Related]
12. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.
Florentin J; Aouar B; Dental C; Thumann C; Firaguay G; Gondois-Rey F; Soumelis V; Baumert TF; Nunès JA; Olive D; Hirsch I; Stranska R
Blood; 2012 Nov; 120(23):4544-51. PubMed ID: 23053572
[TBL] [Abstract][Full Text] [Related]
13. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
14. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
Wilson NR; Bover L; Konopleva M; Han L; Neelapu S; Pemmaraju N
Leuk Lymphoma; 2022 Jan; 63(1):19-30. PubMed ID: 34486917
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of dendritic cells in oral lichen planus.
Santoro A; Majorana A; Roversi L; Gentili F; Marrelli S; Vermi W; Bardellini E; Sapelli P; Facchetti F
J Pathol; 2005 Mar; 205(4):426-34. PubMed ID: 15714455
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells in skin lesions of classic Kaposi's sarcoma.
Karouni M; Kurban M; Abbas O
Arch Dermatol Res; 2016 Sep; 308(7):487-92. PubMed ID: 27372661
[TBL] [Abstract][Full Text] [Related]
17. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2019; 10():112. PubMed ID: 30778353
[No Abstract] [Full Text] [Related]
18. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
[TBL] [Abstract][Full Text] [Related]
19. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ
Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
